Categorized | Health

Commissioners Support Pottstown's Grant Request

Both municipalities are vying for grant money.

SANATOGA PA – A borough of Pottstown PA grant application that seeks $5 million from the state to help defray the $7 million cost of upgrading its water treatment plant, which serves many Lower Pottsgrove Township homes and businesses, received the township Board of Commissioners‘ endorsement Thursday (Aug. 19, 2010).

The reason? The more money Pottstown can obtain from the state, the less water rates paid by all users – including township residents – will rise to cover the cost of the required upgrades, Manager Rodney Hawthorne said.

The borough applied for money under the state’s competitive H2O grant program, Hawthorne said, for Pennsylvania Department of Environmental Protection mandated improvements to its plant’s infrastructure, lagoons, and filtration systems. Pottstown asked for, and by unanimous vote got, a letter of support from commissioners regarding its request. It will be mailed to the state Department of Community Economic Development, which oversees the grant program.

Lower Pottsgrove has at least one H2O grant request of its own in the works, which means it potentially could be racing the borough to a funding finish line. The township would seemingly win in either case.

Related (to the Lower Pottsgrove Board of Commissioners’ Aug. 19 meeting):

Photo from Clipart.com

Sign up to get The Sanatoga Post delivered free daily by e-mail. Share this article.
See our galleries for photos that appear in The Post. Got news for us? E-mail The Post.
Find The Posts on Twitter, Facebook, Linked-In, Technorati, Flickr, YouTube, and RSS

Share

Comments are closed.

From Our Sponsors

RSS Health News

  • Follow-up Avastin shown to benefit colon cancer patients June 3, 2012
    CHICAGO (Reuters) - Colorectal cancer patients treated with a follow-up round of Avastin fare better than those given chemotherapy alone after their disease has worsened, according to results of a large clinical trial. […]
  • Armed antibody delays spread of certain breast cancers June 3, 2012
    CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs. […]
  • J&J hormone-blocking pill slows prostate cancer spread June 2, 2012
    CHICAGO (Reuters) - A trial of Johnson & Johnson's Zytiga in certain prostate cancer patients showed that it doubled the amount of time they lived without the disease getting worse, potentially offering new hope for patients who see their cancer return. […]
  • Bristol immune drug shows promise in three cancers June 2, 2012
    CHICAGO (Reuters) - An experimental Bristol-Myers Squibb drug helped shrink tumors in patients with advanced melanoma, kidney and lung cancers in a preliminary trial, raising hopes for yet another drug that can wake up the immune system and train it to attack cancer cells. […]
  • Hospitals fight drug scarcity, fear patients harmed June 2, 2012
    WASHINGTON (Reuters) - At the Henry Ford Hospital in Detroit, pharmacists are using old-fashioned paper spreadsheets to track their stock of drugs in short supply - a task that takes several hours each day. […]
  • Avastin delays progression of ovarian cancer June 2, 2012
    CHICAGO (Reuters) - Adding cancer drug Avastin to standard chemotherapy doubled the length of time a certain group of advanced ovarian cancer patients lived without their disease getting worse, according to results of a clinical trial. […]
  • U.S., Norway pledge $150 million for maternal health June 2, 2012
    OSLO (Reuters) - The United States and Norway each pledged on Friday to give in the range of $75 million to help protect mothers during labor, delivery and the first 24 hours after birth. […]
  • Walgreen, Express Scripts drop claims against each other June 1, 2012
    (Reuters) - Walgreen Co said on Friday that it and drug benefits manager Express Scripts Holding Co had dropped claims against each other stemming from a September 2011 lawsuit, but said the dismissals did not mean they were any closer to reaching a new deal. […]
  • Do doctor-payment sunshine laws work? June 1, 2012
    NEW YORK (Reuters Health) - The mere passage of a law that requires drug companies to disclose how much money they pay doctors may not change physician prescribing practices, suggests a new study. […]
  • Babies fed soy formula develop as well as others June 1, 2012
    NEW YORK (Reuters Health) - One-year-olds raised on breast milk, regular formula or soy formula seem to fare equally well in brain development, a new study suggests. […]